Inflammatory markers in AD and MCI patients with different biomarker profiles von Schuitemaker, Alie, Dik, Miranda G, Veerhuis, Robert, Scheltens, Philip, Schoonenboom, Niki S.M, Hack, C. Erik, Blankenstein, Marinus A, Jonker, Cees

Volltext

CSF biomarker levels in early and late onset Alzheimer's disease von Bouwman, Femke H, Schoonenboom, Niki S.M, Verwey, Nicolaas A, van Elk, Evert J, Kok, Astrid, Blankenstein, Marinus A, Scheltens, Philip, van der Flier, Wiesje M

Volltext

Effects of processing and storage conditions on amyloid β (1-42) and tau concentrations in cerebrospinal fluid : Implications for use in clinical practice von SCHOONENBOOM, Niki S. M, MULDER, Cees, VANDERSTICHELE, Hugo, VAN ELK, Evert-Jan, KOK, Astrid, VAN KAMP, Gerard J, SCHELTENS, Philip, BLANKENSTEIN, Marinus A

Volltext

What patients want to know, and what we actually tell them: The ABIDE project: Implementation of person‐centered care von Fruijtier, Agnetha D, Visser, Leonie NC, Bouwman, Femke, Lutz, Rogier, Schoonenboom, Niki SM, Kalisvaart, Kees, Hempenius, Liesbeth, Roks, Gerwin, Boelaarts, Leo, Claus, Jules J, Kleijer, Mariska, Beer, Marlijn, van Der Flier, Wiesje, Smets, Ellen M

Volltext

What patients want to know, and what we actually tell them: The ABIDE project von Fruijtier, Agnetha D, Visser, Leonie NC, Bouwman, Femke, Lutz, Rogier, Schoonenboom, Niki SM, Kalisvaart, Kees, Hempenius, Liesbeth, Roks, Gerwin, Boelaarts, Leo, Claus, Jules J, Kleijer, Mariska, Beer, Marlijn, van Der Flier, Wiesje, Smets, Ellen M

Volltext

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease von Schoonenboom, Niki S.M, van der Flier, Wiesje M, Blankenstein, Marinus A, Bouwman, Femke H, Van Kamp, Gerard J, Barkhof, Frederik, Scheltens, Philip

Volltext

Usefulness of longitudinal measurements of beta-amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders von Bouwman, Femke H, van der Flier, Wiesje M, Schoonenboom, Niki S M, van Elk, Evert J, Kok, Astrid, Scheltens, Philip, Blankenstein, Marinus A

Volltext

Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid von Schoonenboom, Niki S M, Mulder, Cees, Vanderstichele, Hugo, Pijnenburg, Yolande A L, Van Kamp, Gerard J, Scheltens, Philip, Mehta, Pankaj D, Blankenstein, Marinus A

Volltext

Usefulness of Longitudinal Measurements of {szligbeta}-Amyloid sub(1-42) in Cerebrospinal Fluid of Patients with Various Cognitive and Neurologic Disorders von Bouwman, Femke H, van der Flier, Wiesje M, Schoonenboom, Niki SM, van Elk, Evert J, Kok, Astrid, Scheltens, Philip, Blankenstein, Marinus A

Volltext